APA (7th ed.) Citation

JY, W., YM, L., WH, H., TH, L., YW, T., PY, H., . . . CC, L. (2025). Comparative effectiveness of tirzepatide versus bariatric metabolic surgery in adults with metabolic-associated steatotic liver disease and obesity: A multi-institutional propensity score-matched study. Hepatology international, 19(5), 1087. https://doi.org/10.1007/s12072-025-10857-9

Chicago Style (17th ed.) Citation

JY, Wu, Lin YM, Hsu WH, Liu TH, Tsai YW, Huang PY, Chuang MH, Yu T, and Lai CC. "Comparative Effectiveness of Tirzepatide Versus Bariatric Metabolic Surgery in Adults with Metabolic-associated Steatotic Liver Disease and Obesity: A Multi-institutional Propensity Score-matched Study." Hepatology International 19, no. 5 (2025): 1087. https://doi.org/10.1007/s12072-025-10857-9.

MLA (9th ed.) Citation

JY, Wu, et al. "Comparative Effectiveness of Tirzepatide Versus Bariatric Metabolic Surgery in Adults with Metabolic-associated Steatotic Liver Disease and Obesity: A Multi-institutional Propensity Score-matched Study." Hepatology International, vol. 19, no. 5, 2025, p. 1087, https://doi.org/10.1007/s12072-025-10857-9.